Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Asset Writedowns and Impairment (2016 - 2020)

Historic Asset Writedowns and Impairment for Surgery Partners (SGRY) over the last 6 years, with Q3 2020 value amounting to $33.5 million.

  • Surgery Partners' Asset Writedowns and Impairment changed N/A to $33.5 million in Q3 2020 from the same period last year, while for Dec 2021 it was $33.5 million, marking a year-over-year decrease of 6752.46%. This contributed to the annual value of $33.5 million for FY2020, which is 32405.06% up from last year.
  • Surgery Partners' Asset Writedowns and Impairment amounted to $33.5 million in Q3 2020.
  • In the past 5 years, Surgery Partners' Asset Writedowns and Impairment ranged from a high of $58.1 million in Q4 2018 and a low of $3.5 million during Q2 2016
  • For the 4-year period, Surgery Partners' Asset Writedowns and Impairment averaged around $13.2 million, with its median value being $7.1 million (2018).
  • As far as peak fluctuations go, Surgery Partners' Asset Writedowns and Impairment plummeted by 2944.46% in 2016, and later surged by 6331.83% in 2017.
  • Quarter analysis of 4 years shows Surgery Partners' Asset Writedowns and Impairment stood at $8.3 million in 2016, then crashed by 41.63% to $4.8 million in 2017, then surged by 1101.9% to $58.1 million in 2018, then crashed by 42.34% to $33.5 million in 2020.
  • Its last three reported values are $33.5 million in Q3 2020, $58.1 million for Q4 2018, and $11.6 million during Q3 2018.